Albert Bourla
@AlbertBourla | 57,580 followers
About 1 in 4 pregnant women carry Group B Streptococcus bacteria that can be passed to their babies, resulting in 147,000+ infant deaths worldwide each year. Today, @US_FDA granted Breakthrough Therapy Designation for our maternal vaccine candidate: on.pfizer.com/3TMoOvr
8 58
  · View on Twitter

Tweet Engagement Stats

Stats are based upon replies and quotes of this tweet

Engagement Map

Quotes
Replies
Retweets
Trendsmap

Replies and Quotes

Total of 5 replies and 3 quotes found
All Replies Quotes Retweeters
In reply to @AlbertBourla
Albert Bourla
@AlbertBourla
With an estimated 410,000 GBS cases worldwide—the largest burden in low- and middle-income countries—we are pursuing a global clinical development strategy with the intent to make a successfully developed vaccine available worldwide as quickly as possible.
  · View on Twitter
 
In reply to @AlbertBourla
Jennifer B.
@JustmeXxx5
Do you think we're stupid Albert ? pic.twitter.com/t1YGtGNnrQ
  · View on Twitter
 
נסיך הגלות והשקר | הקופים והכתר
@nagaslo
והם ממשיכים לחסן
ולחסן ולחסן ולחסן
ולגרוף עוד ועוד ועוד ועוד
ורופאים יצטטו את ה״נתונים״ שלהם
ויעיל, ובטוח, 97%, מגן ממוות…
  · View on Twitter
 
In reply to @AlbertBourla
Average_Joe143
@AverageJoe143
twitter.com/SenRonJohnson/…
  · View on Twitter
 
miklosh van Egan)))
@mikloshvanEgan
Great Pretext , Surely You must be a Scientist..of Sort.
Streptococcus😂need I challenge you on Staphylococcus😂😂 anyway, Lets talk about the meds you stick into a birthing Lady, and once the baby born, you Jab little prince'ss too, of course without telling the mother. pic.twitter.com/OBwAs2okkw
  · View on Twitter
 
In reply to @AlbertBourla
The Genie In The Bottle 🇦🇺🇦🇺
@MeditatingTech
pic.twitter.com/9DzfDKs8oW
  · View on Twitter
 
Over 2 replies and quotes not shown
Top

Retweeters

7 retweeters not shown
Top
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.